Skip to main content
Premium Trial:

Request an Annual Quote

Natera Pre-Emptively Sues Sequenom, Claiming Non-Infringement of Prenatal Diagnosis Patent


Prenatal diagnostics company Natera has sued Sequenom, claiming that it does not infringe a patent on noninvasive prenatal diagnosis held by Sequenom, and that the patent is invalid.

The Redwood City, Calif.-based company, until recently called Gene Security Network, filed its suit on Jan. 6 in the US District Court for the Northern District of California.

In its complaint, Natera seeks a judicial declaration that the noninvasive prenatal paternity test it is developing does not infringe US Patent No. 6,258,540, entitled "Non-invasive prenatal diagnosis." Sequenom licenses the patent, which is assigned to Dennis Lo of the Chinese University of Hong Kong, exclusively from Isis Innovation.

In addition, Natera asked the court to declare that at least one of the patent's claims is invalid "for failure to comply with the requirements" of US patent law, according to Sequenom.

Sequenom said in a statement that it intends to "vigorously defend against the judicial declarations sought in the complaint."

The suit follows a few weeks after Aria Diagnostics, another company developing a noninvasive prenatal test, filed a similar action against Sequenom. In its complaint, Aria also requested a declaration that its test, for the diagnosis of fetal aneuploidies, does not infringe the '540 patent, but it did not contest the patent's validity (CSN 12/21/2011).

The '540 patent is at the core of Sequenom's recently launched MaterniT21 sequencing-based test for the noninvasive prenatal diagnosis of Down syndrome, as well as other prenatal tests the company is developing. The company has stated repeatedly that other groups planning to launch a similar test would infringe the patent.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.